# Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects

> **NCT04570267** · PHASE1 · COMPLETED · sponsor: **CSL Behring** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** CSL324
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04570267
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-08
- **Primary completion:** 2021-11-17
- **Final completion:** 2021-12-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04570267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04570267, "Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04570267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*